Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pds Biotechnology Corp (NQ: PDSB )

3.200 +0.010 (+0.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pds Biotechnology Corp

< Previous 1 2 3 4 5 6 Next >
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q2 2024
PDSB stock results show that PDS Biotechnology beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q1 2024
PDSB stock results show that PDS Biotechnology beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q4 2023
PDSB stock results show that PDS Biotechnology beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Preview For PDS Biotechnology
Via Benzinga
Analyst Expectations for PDS Biotechnology's Future
Via Benzinga
PDS Biotechnology: Q3 Earnings Insights
Via Benzinga
A Preview Of PDS Biotechnology's Earnings
Via Benzinga
Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. 
Via Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in March 2024
These 3 undervalued biotech stocks have been left behind so far but things could begin to turn around as we head into March. 
Via InvestorPlace
The Latest Analyst Ratings for PDS Biotechnology
Via Benzinga
PDS Biotechnology Earnings Preview
Via Benzinga
Why PDS Biotech Shares Are Jumping Today
Via Benzinga
Where PDS Biotechnology Stands With Analysts
Via Benzinga
Earnings Preview For PDS Biotechnology
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
PDS Biotechnology – Top-Line Data From Its Lead Candidate Points To Promising Future For This Company
Frank Bedu-Addo, Ph.D., CEO & Director of PDS Biotechnology (NASDAQ: PDSB), was recently a guest on Benzinga’s All-Access. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Earnings Scheduled For August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool. 
Via Benzinga
Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time for another dive into the biggest pre-market stock movers as we check out what's happening this morning on Friday! 
Via InvestorPlace
Tesla, Costco, Marvell, Ulta Beauty, PDS Biotechnology: Why These 5 Stocks Are Drawing Investor Attention
Via Benzinga
3 Deeply Undervalued Stocks That Could Double Your Money
These cutting-edge biotech stocks hold tremendous upside potential. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.